A study to look at the long-term safety of a medicine, efmarodocokin alfa, in people with ulcerative colitis

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

Autoimmune Disorder
Inflammatory Bowel Disease (IBD)
Crohn's Disease
Ulcerative Colitis

Results
Download

Study results

LPS GA40209 SERENGETI Final Results April 2023 Bulgaria Bulgarian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 English (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Georgia Georgian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Germany German (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Greece Greek (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Italy Italian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Moldova Romanian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Poland Polish (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Russia Russian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Serbia Serbian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Spanish Spain (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Spanish USA (PDF, 0.1 MB)

LPS GA40209 SERENGETI Final Results April 2023 Ukraine Ukrainian (PDF, 0.2 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A study to look at the long-term safety of a medicine, efmarodocokin alfa, in people with ulcerative colitis

Study results

LPS GA40209 SERENGETI Final Results April 2023 Bulgaria Bulgarian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 English (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Georgia Georgian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Germany German (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Greece Greek (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Italy Italian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Moldova Romanian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Poland Polish (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Russia Russian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Serbia Serbian (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Spanish Spain (PDF, 0.2 MB)

LPS GA40209 SERENGETI Final Results April 2023 Spanish USA (PDF, 0.1 MB)

LPS GA40209 SERENGETI Final Results April 2023 Ukraine Ukrainian (PDF, 0.2 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

A study to look at the long-term safety of a medicine, efmarodocokin alfa, in people with ulcerative colitis

For the latest version of this information please go to www.forpatients.roche.com